
Opinion|Videos|July 29, 2024
Current and Potential Obstacles Related to Administering RSV Vaccines
An internal medicine pharmacist discusses current and potential obstacles related to administering RSV vaccines to patients from different age groups.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What have the potential obstacles related to administering RSV vaccines been since approval for patients aged 60+?
- What obstacles do you foresee for patients between 50-59?
- How can these obstacles be overcome?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Value-Based Care Interventions and Management of CKD Progression
5